yingweiwo

Dihydroethidium

Alias: Hydroethidine; PD-MY 003; PD-MY003; PD-MY-003; Hydroethidine; 38483-26-0; 5-ethyl-6-phenyl-5,6-dihydrophenanthridine-3,8-diamine; 5-ethyl-6-phenyl-6H-phenanthridine-3,8-diamine; 5-ethyl-5,6-dihydro-6-phenyl-3,8-phenanthridinediamine; Dihydroethidium?; Dihydroethidium
Cat No.:V2871 Purity: ≥98%
Dihydroethidium (formerly known as Hydroethidine and PD-MY 003) is a cell-permeable blue fluorescent dye and a superoxide indicator which exhibits blue-fluorescence in the cytosol until oxidized, where it intercalates within the cell's DNA, staining its nucleus with a bright fluorescent red.
Dihydroethidium
Dihydroethidium Chemical Structure CAS No.: 104821-25-2
Product category: Reactive Oxygen Species
This product is for research use only, not for human use. We do not sell to patients.
Size Price Stock Qty
5mg
10mg
25mg
50mg
100mg
250mg
500mg
Other Sizes
Official Supplier of:
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text

 

  • Business Relationship with 5000+ Clients Globally
  • Major Universities, Research Institutions, Biotech & Pharma
  • Citations by Top Journals: Nature, Cell, Science, etc.
Top Publications Citing lnvivochem Products
Purity & Quality Control Documentation

Purity: ≥98%

Product Description

Dihydroethidium (formerly known as Hydroethidine and PD-MY 003) is a cell-permeable blue fluorescent dye and a superoxide indicator which exhibits blue-fluorescence in the cytosol until oxidized, where it intercalates within the cell's DNA, staining its nucleus with a bright fluorescent red. DHE-derived fluorescence at 570 nm is a convenient method to detect intracellular and extracellular superoxide produced by phagocytic and vascular NADPH oxidase. In addition, Dihydroethidium is also reported to be neuroprotective by reducing superoxide in mice after stroke.

Biological Activity I Assay Protocols (From Reference)
Targets
superoxide indicator; blue-fluorescence dye
ln Vitro
General procedure:
Preparation of dihydroethidium working solution
1.1 Prepare the stock solution by dissolving 1 mg of dihydroethidium in 0.31 mL DMSO to make 10 mM stock solution.
Note: Avoid repeated freezing and thawing cycle, it is advised that the stock solution be stored at -20°C or -80°C and away from light.
1.2 Preparation of dihydroethidium working solution: Dilute the stock solution into 1–10 μM working solution in PBS or serum-free cell culture medium.
Note: You may adjust the concentration of Dihydroethidium working solution based on your specific needs.
Cell staining
2.1: Suspension cells: Centrifuge 1000g of suspended cells for 3–5 minutes at 4°C; discard supernatant. Use PBS to wash twice, for five minutes each time.
Adherent cells: To isolate the cells and create a single cell suspension, discard the cell culture medium and add trypsin. Discard the supernatant after centrifuging at 1000g for three to five minutes at 4°C. Use PBS to wash twice, for five minutes each time.
2.2 Add 1 mL of the Dihydroethidium working solution, then let it sit at room temperature for half an hour.
2.3 Discard the supernatant after centrifuging at 400 g for three to four minutes at 4°C.
2.4 Wash the cells with PBS twice, five minutes/each time.
2.5 Re-suspend the cells in PBS or serum-free cell culture medium, then use a flow cytometer or fluorescence microscope to observe them. Storage for a year at -20°C with protection from light.
Precautions:
1. The original solution should be kept refrigerated at -20°C or -80°C, shielded from light, and avoid freezing and thaw too frequently.
2. You may adjust the concentration of Dihydroethidium working solution based on your specific needs.
3. This product is intended for research use only.
4. Please wear a lab coat and disposable gloves for your own health and safety when operating.
ln Vivo
Oxidative stress-related indicators in OXA-induced HSOS in mice[2]
The microarray results suggested that oxidative stress may serve an important role in OXA-induced HSOS. Therefore, the levels of common oxidative stress markers were determined and changes in ROS were observed by DHE staining. MDA is a lipid peroxidation product in vivo, which can cause cytotoxicity. The MDA levels in the mice livers were significantly increased following the administration of 10 mg/kg OXA (P<0.05; Fig. 7A). SOD is an antioxidant metal enzyme that can catalyze the superoxide anion radical and provide cellular defenses against ROS. CAT is also an antioxidant enzyme that protects cells from the toxicity of H2O2. GSH has antioxidant and integrative detoxification effects. OXA markedly reduced the levels of SOD, CAT and GSH in the mice livers (P<0.05; Fig. 7B-D). Furthermore, DHE probe technology was used to analyze changes in ROS levels. The results showed that the ROS levels in the livers of the mice in the OXA group were increased in a dose-dependent manner (Fig. 7E). Taken together, these data confirmed that oxidative stress may have an important role in the liver damage of mice with OXA-induced HSOS.
Enzyme Assay
Hydroethidine (HE) or dihydroethidium and its mitochondria-targeted analog conjugated to a triphenylphosphonium moiety (MitoSOXTM Red) react rapidly with superoxide (k ∼106 m−1 s−1), forming a specific hydroxylated marker product, 2-hydroxyethidium (2-OH-E+) or 2-hydroxymitoethidium (2-OH-Mito-E+)[1].
Cell Assay
Intracellular ROS measurements[3]
Two dyes were used to detect ROS: 5-(and-6)-chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate acetyl ester (CM-H2DCFDA: excitation wavelength, 504 nm; emission wavelength, 524 nm) and dihydroethidium (DHE; excitation wavelength, 518 nm; emission wavelength, 605 nm). Both dyes were reconstituted with DMSO. Monocytes and THP-1 cells were incubated with dye at 37°C for 30 min. Cell pellets were resuspended in media and incubated for 15 min at 37°C to allow esterases to cleave CM-H2DCFDA to trap it inside the cell. Cells were then incubated with a2NTD, PMA, or media alone with or without 100 μM diethyldithiocarbamic acid sodium salt trihydrate. Two methods were used to detect intracellular ROS. After a2NTD stimulation, cells were analyzed for fluorescence via flow cytometer on an LSR II or via a microplate reader in a 96-well black plate
Animal Protocol
Staining of dihydroethidium (DHE)-reactive oxygen species (ROS)[2]
Frozen liver sections (−26°C; 6 µm thickness) were warmed at room temperature and mounted with an anti-fluorescence quenching solution for 5 min. ROS dye solution was added dropwise and sections were incubated for 30 min at 37°C in the dark. Subsequently, the sections were washed three times with phosphate-buffered saline (PBS, pH 7.4) and DAPI staining solution was added dropwise and incubated for 10 min at room temperature in the dark. After washing three times with PBS and drying, the sections were mounted with an anti-fluorescence quenching solution. The sections were observed under a fluorescence microscope and images were captured.
References
[1]. Zielonka J, et al. Global profiling of reactive oxygen and nitrogen species in biological systems: high-throughput real-time analyses. J Biol Chem. 2012 Jan 27;287(5):2984-95.
Model establishment and microarray analysis of mice with oxaliplatin‑induced hepatic sinusoidal obstruction syndrome. Mol Med Rep . 2022 Nov;26(5):346.
[3]. Tumor-associated a2 vacuolar ATPase acts as a key mediator of cancer-related inflammation by inducing pro-tumorigenic properties in monocytes. J Immunol. 2011 Feb 1;186(3):1781-9.
Additional Infomation
Cancer-related inflammation profoundly affects tumor progression. Tumor-associated macrophages (TAMs) are known regulators of that inflammation, but the factors that initiate cancer-related inflammation are poorly understood. Tumor invasiveness and poor clinical outcome are linked to increased expression of cell surface-associated vacuolar adenosine triphosphatases. The a2 isoform vacuolar adenosine triphosphatase is found on the surface on many solid tumors, and we have identified a peptide cleaved from a2 isoform vacuolar adenosine triphosphatase called a2NTD. a2NTD has properties necessary to induce monocytes into a pro-oncogenic TAM phenotype. The peptide upregulated both pro- and anti-inflammatory mediators. These included IL-1β and IL-10, which are important in promoting inflammation and immune escape by tumor cells. The secretion of inflammatory cytokine IL-1β was dependent on ATP, K(+) efflux, and reactive oxygen species, all mediators that activate the inflammasome. These findings describe a mechanism by which tumor cells affect the maturation of TAMs via a nontraditional cytokine-like signal, the a2NTD peptide.[3]
Herein we describe a high-throughput fluorescence and HPLC-based methodology for global profiling of reactive oxygen and nitrogen species (ROS/RNS) in biological systems. The combined use of HPLC and fluorescence detection is key to successful implementation and validation of this methodology. Included here are methods to specifically detect and quantitate the products formed from interaction between the ROS/RNS species and the fluorogenic probes, as follows: superoxide using hydroethidine, peroxynitrite using boronate-based probes, nitric oxide-derived nitrosating species with 4,5-diaminofluorescein, and hydrogen peroxide and other oxidants using 10-acetyl-3,7-dihydroxyphenoxazine (Amplex® Red) with and without horseradish peroxidase, respectively. In this study, we demonstrate real-time monitoring of ROS/RNS in activated macrophages using high-throughput fluorescence and HPLC methods. This global profiling approach, simultaneous detection of multiple ROS/RNS products of fluorescent probes, developed in this study will be useful in unraveling the complex role of ROS/RNS in redox regulation, cell signaling, and cellular oxidative processes and in high-throughput screening of anti-inflammatory antioxidants.[2]
Hepatic sinusoidal obstruction syndrome (HSOS) is a serious side effect of oxaliplatin (OXA) treatment. The present study aimed to establish a reproducible mouse model of OXA‑induced HSOS and to preliminarily explore the underlying molecular mechanisms using mRNA microarray analysis. A total of 45 C57BL/6 male mice were randomly divided into five groups: Control, 5 mg/kg OXA, 10 mg/kg OXA, 15 mg/kg OXA and 20 mg/kg OXA. The mice were respectively injected intraperitoneally with 5% glucose solution, or 5, 10, 15 or 20 mg/kg OXA solution once a week for 6 consecutive weeks. The body weight of the mice was recorded every day. The serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were determined. Hematoxylin and eosin staining, Sirius red staining and scanning electron microscopy were used to identify pathological changes. mRNA microarray was used to analyze changes in the gene expression profiles mainly from the functional aspects of Gene Ontology and the Kyoto Encyclopedia of Genes and Genomes. The oxidation mechanism was verified by measuring oxidative stress‑related markers and reactive oxygen species with dihydroethidium probe technology, according to the microarray results. Among all of the OXA groups, 10 mg/kg OXA resulted in an acceptable survival rate of 78%. The mice showed obvious splenomegaly, increases in serum levels of ALT and AST, aggravation of liver pathological injuries and hepatic sinusoidal injuries. The microarray results suggested that mRNA expression changes after OXA treatment were associated with 'oxidative stress', 'coagulation function', 'steroid anabolism' and 'pro‑inflammatory responses'. The results confirmed that OXA aggravated oxidative damage in the livers of the mice. The present study successfully established a mouse model of OXA‑induced HSOS and preliminarily analyzed the underlying molecular mechanisms involved, thus laying a foundation for a subsequent in‑depth study.[1]
These protocols are for reference only. InvivoChem does not independently validate these methods.
Physicochemical Properties
Molecular Formula
C21H21N3
Molecular Weight
315.41
Exact Mass
315.17
Elemental Analysis
C, 79.97; H, 6.71; N, 13.32
CAS #
104821-25-2
Related CAS #
104821-25-2
PubChem CID
128682
Appearance
Pale purple to light pink solid powder
LogP
3.06
tPSA
55.92
SMILES
NC1=CC=C2C3=C(C=C(N)C=C3)C(C4=CC=CC=C4)N(CC)C2=C1
InChi Key
XYJODUBPWNZLML-UHFFFAOYSA-N
InChi Code
InChI=1S/C21H21N3/c1-2-24-20-13-16(23)9-11-18(20)17-10-8-15(22)12-19(17)21(24)14-6-4-3-5-7-14/h3-13,21H,2,22-23H2,1H3
Chemical Name
5-ethyl-6-phenyl-6H-phenanthridine-3,8-diamine
Synonyms
Hydroethidine; PD-MY 003; PD-MY003; PD-MY-003; Hydroethidine; 38483-26-0; 5-ethyl-6-phenyl-5,6-dihydrophenanthridine-3,8-diamine; 5-ethyl-6-phenyl-6H-phenanthridine-3,8-diamine; 5-ethyl-5,6-dihydro-6-phenyl-3,8-phenanthridinediamine; Dihydroethidium?; Dihydroethidium
HS Tariff Code
2934.99.9001
Storage

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Note: This product requires protection from light (avoid light exposure) during transportation and storage.
Shipping Condition
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
Solubility Data
Solubility (In Vitro)
DMSO:10 mM in DMSO
Water:<1 mg/mL
Ethanol:
Solubility (In Vivo)
Solubility in Formulation 1: ≥ 2.5 mg/mL (7.93 mM) (saturation unknown) in 10% DMSO + 40% PEG300 +5% Tween-80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 + to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 3.1705 mL 15.8524 mL 31.7048 mL
5 mM 0.6341 mL 3.1705 mL 6.3410 mL
10 mM 0.3170 mL 1.5852 mL 3.1705 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.

Calculator

Molarity Calculator allows you to calculate the mass, volume, and/or concentration required for a solution, as detailed below:

  • Calculate the Mass of a compound required to prepare a solution of known volume and concentration
  • Calculate the Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Calculate the Concentration of a solution resulting from a known mass of compound in a specific volume
An example of molarity calculation using the molarity calculator is shown below:
What is the mass of compound required to make a 10 mM stock solution in 5 ml of DMSO given that the molecular weight of the compound is 350.26 g/mol?
  • Enter 350.26 in the Molecular Weight (MW) box
  • Enter 10 in the Concentration box and choose the correct unit (mM)
  • Enter 5 in the Volume box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 17.513 mg appears in the Mass box. In a similar way, you may calculate the volume and concentration.

Dilution Calculator allows you to calculate how to dilute a stock solution of known concentrations. For example, you may Enter C1, C2 & V2 to calculate V1, as detailed below:

What volume of a given 10 mM stock solution is required to make 25 ml of a 25 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=25 μM, V2=25 ml and V1 is the unknown:
  • Enter 10 into the Concentration (Start) box and choose the correct unit (mM)
  • Enter 25 into the Concentration (End) box and select the correct unit (mM)
  • Enter 25 into the Volume (End) box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 62.5 μL (0.1 ml) appears in the Volume (Start) box
g/mol

Molecular Weight Calculator allows you to calculate the molar mass and elemental composition of a compound, as detailed below:

Note: Chemical formula is case sensitive: C12H18N3O4  c12h18n3o4
Instructions to calculate molar mass (molecular weight) of a chemical compound:
  • To calculate molar mass of a chemical compound, please enter the chemical/molecular formula and click the “Calculate’ button.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
  • Molecular mass (or molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
  • Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
/

Reconstitution Calculator allows you to calculate the volume of solvent required to reconstitute your vial.

  • Enter the mass of the reagent and the desired reconstitution concentration as well as the correct units
  • Click the “Calculate” button
  • The answer appears in the Volume (to add to vial) box
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal to make allowance for loss during the experiment)
Step 2: Enter in vivo formulation (This is only a calculator, not the exact formulation for a specific product. Please contact us first if there is no in vivo formulation in the solubility section.)
+
+
+

Calculation results

Working concentration mg/mL;

Method for preparing DMSO stock solution mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation:Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.

(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
             (2) Be sure to add the solvent(s) in order.

Biological Data
  • Dihydroethidium


    Oxidation of HE by O2˙̄,•NO, and co-generated•NO and O2˙̄and global profiling of products.2012 Jan 27;287(5):2984-95.

  • Dihydroethidium


    Real-time monitoring of products of HE oxidation by activated macrophages.2012 Jan 27;287(5):2984-95.

  • Dihydroethidium


    Global profiling of H2O2and ONOO−-derived oxidants by monitoring the oxidation of Amplex® Red.2012 Jan 27;287(5):2984-95.

Contact Us